Beckman Coulter Diagnostics

Join Us for a Live Symposium Presentation at AD/PD 2025! 🧠🔬 We are excited to invite you to our live symposium presentation on Tuesday, April 1st at 13:15 – 15:30. Don't miss this opportunity to hear from Paul Wynveen, Sr. Staff Development Scientist, as he presents: Lecture Title: Performance of Beckman Coulter Prototype Plasma p-Tau217 And p-Tau217/Aβ42 Ratio Assays in a Cohort of Individuals with Cognitive Impairment Lecture Time: 14:15 – 14:30 Location: Hall A Symposium Session: Biomarkers, Imaging, and Translational Aspects Add this event to your calendar now! https://bit.ly/3FyTyxB #ADPD2025 #Neurology #Biomarkers #DiagnosticInnovation #Neurodegeneration #HealthcareInnovation

Discover the future of blood-based Alzheimer's tests in an article by our Chief Medical Officer, Zivjena Vucetic, featured in The Pathologist. She highlights the global efforts to develop a more accessible, less invasive, and cost-effective blood-based Alzheimer’s test and the crucial role of cross-sector partnerships in meeting patient needs. Check it out here: https://bit.ly/4hp8bk8 #InTheNews #BeckmanCoulterDiagnostics #AlzheimersDisease #DanaherNews 

Why do you see "Beckman" all over Irvine? It's the legacy of Dr. Arnold O. Beckman, a pioneering scientist and philanthropist. He revolutionized chemistry with the first electronic pH meter, founded Beckman Instruments (now Beckman Coulter Diagnostics), and shaped science, education, and tech. His impact continues through the Arnold and Mabel @Beckman Foundation, with contributions to Caltech, University of Illinois, and beyond. He worked alongside visionaries like Carl “Speed” Marvel, Søren Sørensen, William Shockley, and Gordon E. Moore, and even played a role in the rise of Silicon Valley. https://lnkd.in/dHz9fcyz #Science #Innovation #Tech #STEM #Invention #TechInnovation # #Engineering #ScientificInventions #OCStartups #OCSC #GrowthOC #OrangeCounty #California Kaerie Ray, MBA, PMP Anne Hultgren Scott Fox 🦊

Calling all AD/PD 2025 participants! 🧠 We are excited to see you at AD/PD 2025. Join us in Booth #44 to discover our latest research and innovations in the fields of Alzheimer's and Parkinson's diseases. Here's our schedule: #ADPD2025

Traditional Alzheimer's diagnostics like CSF analysis and PET scans are effective but expensive and not scalable. Blood-based biomarkers offer a promising alternative for early and accessible detection. Read blog >> https://bit.ly/42Xe5FL #healthcare #diagnostics #neurologicalresearch #neurodegenerativedisease #alzheimers #dementia #endalz #neuroscience #neuroscientist #researcher

In this year’s #GWCChallenge, we’re challenging our students to build a project that explores how people can use AI to create a more sustainable future. We are on the edge of our seats while these projects are currently being judged by representatives from our incredible partners. The winners will be announced on 3/25 but in the meantime, let's introduce you to these amazing judges! Meet Nicole Shin McGee, Vice President of Information Technology and Chief Information Officer, at Beckman Coulter Diagnostics. “Diverse teams bring varied perspectives, which can lead to more innovative solutions and products,” says McGee. “By supporting Girls Who Code, we can collectively foster a culture of creativity and innovation within their organizations.  I am excited to participate in this event as AI and innovation will drive significant changes in the workforce by creating new opportunities, enhancing productivity, and enabling a more adaptive and resilient work environment."

Learn about our newly available high-throughput, fully automated immunoassay for plasma neurofilament light chain (NfL), a promising biomarker demonstrating neuro axonal damage in a variety of neurological conditions. With our newly available NfL assay, you can run up to 450 NfL tests/hour on the DxI 9000 analyzer and 100 NfL tests per hour on the Access 2 analyzer on both EDTA plasma and serum samples. How does our RUO assay compare with other commercially available NfL assays? Read the study to find out! 📥 Download poster >>https://bit.ly/40TKtrQ 🌐 Learn more about our RUO assays>> https://bit.ly/40AxUQf #NeurologicalResearch #Healthcare #Diagnostics #NeurodegenerativeDisease

News Release: Beckman Coulter Announces FDA clearance of DxC 500i Clinical Analyzer, an integrated Clinical Chemistry and Immunoassay System https://bit.ly/41DwapJ #diagnostics, #clinicalchemistry #innovation

For International Women’s Day, how can you #AccelerateAction? Strike the #IWD2025 pose 💪and show your support! At Danaher Corporation and Beckman Coulter, we have collaborated across our workforce to bring this theme to life in our programming, communications and events. We have worked diligently in prior years to achieve a richly varied workforce where our associates’ different backgrounds, experiences and perspectives have created a more inclusive workplace and a sense of belonging. However, there is always more we could do to actively demonstrate our core value, “Best Team Wins” and our core behavior “Win as a Team.” #IWD Kevin O'Reilly, Rachel Trace, Kiran Rathod, Grady Davis, Marianne Helstrup, Douglas Lee, Liezl Naude, Rasha Al Jayyousi, Sarah Foster, Peter Katona, Elaine Beliakoff, Vivienne Saunders, Brad Morse, Matthew Rhyner, Claudine Vo, SPHR, Erin Selin, Jose A. Crespo, Philipp Steinmann, Rob Young, Elke Dörner, Jin Yong, CPA, MBA, Jose Bermudez

It’s been a great two weeks in Athens and Orlando with our Europe and North America commercial teams. What an energizing start to 2025! We’re Relentless as One and poised to make a difference for our laboratory partners and the patients they serve. Special thanks to Rachel Trace , Matthew Miller and our leadership teams for hosting a warm welcome for our new Chief Commercial Officer Laurent Amiel. I’m excited for what’s ahead for Beckman Coulter Diagnostics!